Maan El Halabi

Maan El Halabi

Auto-generated profile, based on publicly available information

Maan El Halabi

Tufts Medical Center, Boston, MA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in Expert Review of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
MHMaan El Halabi
Maan El Halabi
HPHenry Parkman
Henry Parkman
Gastroparesis is characterized by symptoms suggesting gastric retention of food and objective evidence of delayed gastric emptying in the absence of a mechanical obstruction. Nausea, vomiting, earl...

27 August 2019 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
MHMaan El Halabi
Maan El Halabi
HDHalim Bou Daher
Halim Bou Daher
LRLuma Basma O. Rustom
Luma Basma O. Rustom
MMMajd Marrache
Majd Marrache
YIYervant Ichkhanian
Yervant Ichkhanian
ASAla I. Sharara
Ala I. Sharara
Background Serum lipase is a rapid and reliable laboratory test central to diagnosing acute pancreatitis (AP). Routine use in the emergency department (ED) setting for all cases of abdominal pain or as part of a standard laboratory biochemical profile may lead to unnecessary expenses. Aim Examine the utility of serum lipase determination at a tertiary care center ED. Methods Retrospective cross‐sectional study of ED patients having serum lipase determination over a 12‐month period. Electronic medical records were reviewed for indication and interpretation leading to additional diagnostic imaging, specialist consultation, interventions or hospital admission. Results A total of 24,133 adult patients visited the ED during the study period: 4,976 (20.6%) had serum lipase determination, 614 (12.4%) had abnormal lipase, 130 of which (21.1%) were above the diagnostic threshold for AP (>3xULN). A total of 75 patients had confirmed AP (0.3% of all adult ED visits). The positive and negative predictive values of serum lipase (>3xULN) for AP were 43.6% and 99.6% respectively. 1,890 patients (38.0%) had no abdominal pain on history or physical examination. In this group, the total charges associated with lipase determination was $51,030 with 251 (13.3%) elevated lipase values triggering cross‐sectional abdominal imaging in 61 (24.3%) patients and unwarranted gastroenterology consultation in 3 (1.2%) for an additional charge of $28,975. Conclusions Serum lipase is widely overutilized in the emergency setting resulting in unnecessary expenses and investigations. Evidence‐based review of clinical guidelines and more restrictive testing can result in substantial cost savings and improved patient care.

11 October 2024 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
MHMaan El Halabi
Maan El Halabi
CSCarla Saoud
Carla Saoud
SNSelim M Nasser
Selim M Nasser
Background: Lymphocytic esophagitis (LyE) is a rare condition that has been reported in several case studies, but its diagnostic criteria and clinical significance are inconsistent. There are no established clinical associations, except for Crohn’s disease in children. Our study aimed to determine if patients with LyE have distinct demographic or clinical characteristics when compared with patients with increased intraepithelial lymphocytes (IEL) in their esophageal biopsy. Methods: We conducted a retrospective review of all esophageal biopsies between 2008 and 2023 in 2 medical centers. After excluding cases that met criteria for specific disorders, we identified all cases with increased IEL and compared their clinical, demographic, and endoscopic characteristics to those of LyE. Results: We identified 381 cases with increased IEL, of which 15 met the criteria for LyE. Patients diagnosed with LyE showed no distinctive demographic, endoscopic, or associated morbidities. The gradual increase in esophageal IEL was not associated with any differences in demographic, endoscopic, or clinicopathologic findings. Conclusion: Our findings suggest that lymphocytic esophagitis is not a well-defined clinicopathologic entity but rather a rare and nonspecific histologic pattern associated with various esophageal disorders. Further studies should aim to differentiate between the underlying causes of this histologic pattern, rather than defining it as a single clinicopathologic entity.

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
NKNour Al Khalili
Nour Al Khalili
MSMantej Sehmbhi
Mantej Sehmbhi
ESEmily Seltzer
Emily Seltzer
CCChristy Chon
Christy Chon
MHMaan El Halabi
Maan El Halabi
MSMichael S. Smith
Michael S. Smith